Advertisement

Family Practice

Home Family Practice
COVID-19 is associated with a high rate of pulmonary embolism

High Rate of Pulmonary Embolism Found for Patients With COVID-19

Two studies demonstrate high rate of PE; 100 percent sensitivity for PE seen for D-dimer level > 2,660 µg/L
High-dosage chloroquine diphosphate has potential safety hazards when used as adjunctive therapy for patients hospitalized with severe COVID-19

Adding High-Dose Chloroquine Not Advised for Severe COVID-19

High-dose versus low-dose group had higher lethality until day 13, more instances of QTc interval >500 ms
Persons aged 60 to 69 years with COVID-19 are the most commonly hospitalized

Patients Aged 60 to 69 Most Often Hospitalized With COVID-19

At California KPNC hospitals, most common age group hospitalized, admitted to ICU was those aged 60 to 69 years
The use of smartphone-enabled health monitoring devices after myocardial infarction yields similar blood pressure control when compared with regular follow-up visits

Mobile BP Monitoring Does Not Change Outcomes After Myocardial Infarction

Blood pressure and patient satisfaction similar in smartphone device and regular follow-up groups
A number of former American-style football players report clinician-diagnosed chronic traumatic encephalopathy

Former Footballers Report Chronic Traumatic Encephalopathy Symptoms

Although a postmortem diagnosis, clinician-diagnosed CTE reported by 2.8 percent of American football players
Severe acute respiratory syndrome coronavirus 2 is not detected in the semen of patients one month after COVID-19 diagnosis

SARS-CoV-2 Not Detected in Semen After COVID-19 Recovery

At one month after COVID-19 diagnosis, SARS-CoV-2 not detected in seminal fluid
A single symptomatic COVID-19 infection results in direct medical costs of $3

Direct Medical Costs of COVID-19 Infection Are Considerable

Costs could vary from $163.4 to $654.0 billion for 20 to 80 percent of U.S. population infected, respectively
In an international expert consensus statement

Recommendations Issued for Imaging Use in Pediatric COVID-19

Recommendations applicable for mild COVID-19, moderate-severe COVID-19 with, without resource constraints
Some companies are selling hand sanitizers with unproven claims that they will protect against COVID-19

FDA Warns of Bogus Claims by Makers of Hand Sanitizer

No evidence hand-sanitizing products can protect consumers for 24 hours or after multiple hand washings
On Monday

FDA Bans Products That Help Kids Hide Vape Use From Parents

Companies risk additional FDA action if they do not stop manufacture, distribution, and sale of these products